Journal of Clinical Tuberculosis and Other Mycobacterial Diseases Volume 34

Announcement and Overview: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Major Announcement: We are elated to announce that the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases has achieved significant milestones by being indexed on both PubMed and ESCI. This recognition is a testament to the journal’s commitment to advancing the scientific understanding and clinical management of tuberculosis and related diseases.

About the Journal:

The Journal of Clinical Tuberculosis and Other Mycobacterial Diseases stands as a dedicated platform addressing all clinically pertinent facets of tuberculosis and associated mycobacterial infections. With an unwavering commitment to disseminating knowledge, the journal’s coverage is both expansive and incisive, including:

1. Epidemiology: Tracking the patterns, causes, and effects of tuberculosis and other mycobacterial diseases, offering critical insights for intervention strategies.
2. Clinical Investigation: Delving deep into clinical research and studies, providing a robust understanding of the disease’s manifestations, management, and prognosis.
3. Transmission Dynamics: Understanding how tuberculosis and related diseases spread across populations and devising strategies to curtail this spread.
4. Diagnostic Strategies: Highlighting cutting-edge tools, methodologies, and best practices in diagnosing tuberculosis and other mycobacterial infections.
5. Treatment Modalities: Offering a comprehensive understanding of current treatment protocols, innovative therapeutic strategies, and challenges in managing the disease.
6. Drug-resistance: Shining a spotlight on the looming threat of drug-resistant strains, their implications, and strategies to combat them.
7. Public Policy: Discussing the interplay between clinical understanding and public health policy, ensuring a holistic approach to tackling the disease.
8. Case Reports and Thematic Reviews: Inviting in-depth reviews on thematic areas and intriguing case reports that offer unique insights and learnings.

In alignment with its commitment to accessibility and dissemination of knowledge, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases operates under an Open Access model, ensuring that its rich repository of knowledge is available to researchers, clinicians, policymakers, and the general public without barriers.

Conclusion: The Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is more than just a publication; it’s a mission-driven platform dedicated to making strides in the understanding and management of a group of diseases that have significant global implications. This indexing is just another step in its journey of contributing to global health and well-being.

Volume 34: February 2024